loadpatents
Patent applications and USPTO patent grants for Nishimura; Chihiro.The latest application filed is for "medicament for treatment of bone marrow suppression, for treatment of infectious diseases and for increasing the number of leukocytes".
Patent | Date |
---|---|
.alpha.-Amino-N-(diaminophosphinyl)lactam derivatives Grant 7,348,318 - Abe , et al. March 25, 2 | 2008-03-25 |
Medicament for treatment of bone marrow suppression, for treatment of infectious diseases and for increasing the number of leukocytes Grant 7,247,640 - Yamashita , et al. July 24, 2 | 2007-07-24 |
Medicament for treatment of bone marrow suppression, for treatment of infectious diseases and for increasing the number of leukocytes App 20050256090 - Yamashita, Takumi ;   et al. | 2005-11-17 |
Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative App 20050164989 - Abe, Masatoshi ;   et al. | 2005-07-28 |
Medicament for treatment of bone marrow suppression, for treatment of infectious diseases and for increasing the number of leukocytes App 20040038942 - Yamashita, Takumi ;   et al. | 2004-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.